Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 671

1.

Impact of Abdominal Aortic Calcification among Liver Transplant Recipients: A Retrospective Study.

Imaoka Y, Ohira M, Nakano R, Shimizu S, Kuroda S, Tahara H, Ide K, Kobayashi T, Ohdan H.

Liver Transpl. 2018 Jul 18. doi: 10.1002/lt.25311. [Epub ahead of print]

PMID:
30021054
2.

Hybrid Surgery for Portosystemic Encephalopathy in a Patient with Liver Cirrhosis: a case report.

Imaoka Y, Ohira M, Kuroda S, Tahara H, Ide K, Ishiyama K, Kobayashi T, Ishikawa M, Awai K, Ohdan H.

Hiroshima J Med Sci. 2017 Mar;66(1):11-15.

PMID:
29986123
3.

Neoadjuvant Radiotherapy with Capecitabine Plus Bevacizumab for Locally Advanced Lower Rectal Cancer: Results of a Single-institute Phase II Study.

Maeda K, Shibutani M, Otani H, Fukuoka T, Iseki Y, Matsutani S, Nagahara H, Inoue T, Tachimori A, Nishii T, Miki Y, Hosono M, Ohira M.

Anticancer Res. 2018 Jul;38(7):4193-4197. doi: 10.21873/anticanres.12713.

PMID:
29970549
4.

The prognostic value of the systemic inflammatory score in patients with unresectable metastatic colorectal cancer.

Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kimura K, Amano R, Hirakawa K, Ohira M.

Oncol Lett. 2018 Jul;16(1):666-672. doi: 10.3892/ol.2018.8628. Epub 2018 May 4.

5.

The simple method for predicting metabolic equivalents using heart rate in patients with cardiovascular disease.

Yamamoto S, Ishida T, Misawa K, Ohira M, Yajima F, Higuchi S, Yamasaki S, Yoshimura Y.

Int J Cardiol Heart Vasc. 2018 May 30;19:88-89. doi: 10.1016/j.ijcha.2018.05.005. eCollection 2018 Jun. No abstract available.

6.

Hepatic irradiation persistently eliminates liver resident NK cells.

Nakano R, Ohira M, Yano T, Imaoka Y, Tanaka Y, Ohdan H.

PLoS One. 2018 Jun 13;13(6):e0198904. doi: 10.1371/journal.pone.0198904. eCollection 2018.

7.

Lymphocyte-to-Monocyte Ratio is a Predictor of Survival after Liver Transplantation for Hepatocellular Carcinoma.

Mano Y, Yoshizumi T, Yugawa K, Ohira M, Motomura T, Toshima T, Itoh S, Harada N, Ikegami T, Soejima Y, Maehara Y.

Liver Transpl. 2018 Jun 12. doi: 10.1002/lt.25204. [Epub ahead of print]

PMID:
29893464
8.

Synthesis of Poly(3,4-ethylenedioxythiophene)-Platinum and Poly(3,4-ethylenedioxythiophene)-Poly(styrenesulfonate) Hybrid Fibers by Alternating Current Bipolar Electropolymerization.

Koizumi Y, Ohira M, Watanabe T, Nishiyama H, Tomita I, Inagi S.

Langmuir. 2018 Jul 3;34(26):7598-7603. doi: 10.1021/acs.langmuir.8b00408. Epub 2018 Jun 21.

PMID:
29889536
9.

The significance of scirrhous gastric cancer cell lines: the molecular characterization using cell lines and mouse models.

Yashiro M, Matsuoka T, Ohira M.

Hum Cell. 2018 Jun 6. doi: 10.1007/s13577-018-0211-4. [Epub ahead of print] Review.

PMID:
29876827
10.

Clinical Relevance of Postoperative Neutrophil-Lymphocyte Ratio (NLR) to Recurrence After Adjuvant Chemotherapy of S-1 for Gastric Cancer.

Tanaka H, Tamura T, Toyokawa T, Muguruma K, Miki Y, Kubo N, Sakurai K, Hirakawa K, Ohira M.

Anticancer Res. 2018 Jun;38(6):3745-3751. doi: 10.21873/anticanres.12655.

PMID:
29848737
11.

Hepatectomy versus stereotactic body radiotherapy for primary early hepatocellular carcinoma: A propensity-matched analysis in a single institution.

Nakano R, Ohira M, Kobayashi T, Ide K, Tahara H, Kuroda S, Shimizu S, Kimura T, Nagata Y, Aikata H, Chayama K, Ohdan H.

Surgery. 2018 May 22. pii: S0039-6060(18)30129-6. doi: 10.1016/j.surg.2018.03.006. [Epub ahead of print]

PMID:
29801728
12.

Lymph Node Metastasis of Mixed Adenoneuroendocrine Carcinoma after Curative Resection Using the Expanded Criteria for Early Gastric Cancer.

Ochiai T, Ominami M, Nagami Y, Fukunaga S, Toyokawa T, Yamagami H, Tanigawa T, Watanabe T, Ohira M, Ohsawa M, Fujiwara Y.

Intern Med. 2018 May 18. doi: 10.2169/internalmedicine.0311-17. [Epub ahead of print]

13.

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Morisaki T, Takashima T, Tomita S, Hirakawa K, Ohira M.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1547-1559. doi: 10.1007/s00432-018-2670-0. Epub 2018 May 19.

PMID:
29779135
14.

Prognostic factors in patients with recurrent intrahepatic cholangiocarcinoma after curative resection: A retrospective cohort study.

Ohira M, Kobayashi T, Hashimoto M, Tazawa H, Abe T, Oshita A, Kohashi T, Irei T, Oishi K, Ohdan H; Hiroshima Surgical study group of Clinical Oncology (HiSCO).

Int J Surg. 2018 Jun;54(Pt A):156-162. doi: 10.1016/j.ijsu.2018.04.058. Epub 2018 May 3.

PMID:
29730072
15.

Eribulin Promotes Antitumor Immune Responses in Patients with Locally Advanced or Metastatic Breast Cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 May;38(5):2929-2938.

PMID:
29715119
16.

Results of a phase II trial for high-risk neuroblastoma treatment protocol JN-H-07: a report from the Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Hishiki T, Matsumoto K, Ohira M, Kamijo T, Shichino H, Kuroda T, Yoneda A, Soejima T, Nakazawa A, Takimoto T, Yokota I, Teramukai S, Takahashi H, Fukushima T, Kaneko T, Hara J, Kaneko M, Ikeda H, Tajiri T, Nakagawara A; Japan Childhood Cancer Group Neuroblastoma Committee (JNBSG).

Int J Clin Oncol. 2018 Apr 26. doi: 10.1007/s10147-018-1281-8. [Epub ahead of print]

PMID:
29700636
17.

A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.

Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M.

PLoS One. 2018 Apr 26;13(4):e0192744. doi: 10.1371/journal.pone.0192744. eCollection 2018.

18.

Clinical Significance of the Neutrophil-to-Lymphocyte Ratio in Endocrine Therapy for Stage IV Breast Cancer.

Iimori N, Kashiwagi S, Asano Y, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Hirakawa K, Ohira M.

In Vivo. 2018 May-Jun;32(3):669-675.

19.

Meta-analysis of Robot-assisted Versus Laparoscopic Surgery for Rectal Cancer.

Ohtani H, Maeda K, Nomura S, Shinto O, Mizuyama Y, Nakagawa H, Nagahara H, Shibutani M, Fukuoka T, Amano R, Hirakawa K, Ohira M.

In Vivo. 2018 May-Jun;32(3):611-623.

20.

Neutrophils in primary gastric tumors are correlated with neutrophil infiltration in tumor-draining lymph nodes and the systemic inflammatory response.

Hiramatsu S, Tanaka H, Nishimura J, Sakimura C, Tamura T, Toyokawa T, Muguruma K, Yashiro M, Hirakawa K, Ohira M.

BMC Immunol. 2018 Apr 16;19(1):13. doi: 10.1186/s12865-018-0251-2.

21.

A case of complete splenic infarction after laparoscopic spleen-preserving distal pancreatectomy.

Kimura K, Ohira G, Amano R, Yamazoe S, Tanaka R, Tauchi J, Ohira M.

BMC Surg. 2018 Apr 10;18(1):22. doi: 10.1186/s12893-018-0353-z.

22.

Verification of the methodology for evaluating tumor-infiltrating lymphocytes in colorectal cancer.

Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Iseki Y, Hirakawa K, Ohira M.

Oncotarget. 2018 Mar 8;9(20):15180-15197. doi: 10.18632/oncotarget.24612. eCollection 2018 Mar 16.

23.

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Takahashi K, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 3;16(1):86. doi: 10.1186/s12967-018-1460-4.

24.

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Apr 4;16(1):87. doi: 10.1186/s12967-018-1458-y.

25.

A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study.

Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Kashiwagi S, Tanaka H, Hirakawa K, Ohira M.

BMC Cancer. 2018 Apr 3;18(1):371. doi: 10.1186/s12885-018-4276-y.

26.

Prediction of Treatment Response to Neoadjuvant Chemotherapy in Breast Cancer by Subtype Using Tumor-infiltrating Lymphocytes.

Asano Y, Kashiwagi S, Goto W, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2311-2321.

PMID:
29599354
27.

Analysis of HER Family (HER1-4) Expression as a Biomarker in Combination Therapy with Pertuzumab, Trastuzumab and Docetaxel for Advanced HER2-positive Breast Cancer.

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Fujita H, Takashima T, Ohsawa M, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2285-2294.

PMID:
29599351
28.

MicroRNA-96 Promotes Tumor Invasion in Colorectal Cancer via RECK.

Iseki Y, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Matsutani S, Hirakawa K, Ohira M.

Anticancer Res. 2018 Apr;38(4):2031-2035.

PMID:
29599320
29.

Correction to: Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer.

Goto W, Kashiwagi S, Asano Y, Takada K, Takahashi K, Hatano T, Takashima T, Tomita S, Motomura H, Ohsawa M, Hirakawa K, Ohira M.

Biomark Res. 2018 Mar 7;6:9. doi: 10.1186/s40364-018-0124-0. eCollection 2018.

30.

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment.

Kashiwagi S, Tsujio G, Asano Y, Goto W, Takada K, Takahashi K, Morisaki T, Fujita H, Takashima T, Tomita S, Ohsawa M, Hirakawa K, Ohira M.

J Transl Med. 2018 Mar 9;16(1):54. doi: 10.1186/s12967-018-1443-5.

31.

Genomic Amplifications and Distal 6q Loss: Novel Markers for Poor Survival in High-risk Neuroblastoma Patients.

Depuydt P, Boeva V, Hocking TD, Cannoodt R, Ambros IM, Ambros PF, Asgharzadeh S, Attiyeh EF, Combaret V, Defferrari R, Fischer M, Hero B, Hogarty MD, Irwin MS, Koster J, Kreissman S, Ladenstein R, Lapouble E, Laureys G, London WB, Mazzocco K, Nakagawara A, Noguera R, Ohira M, Park JR, Pötschger U, Theissen J, Tonini GP, Valteau-Couanet D, Varesio L, Versteeg R, Speleman F, Maris JM, Schleiermacher G, De Preter K.

J Natl Cancer Inst. 2018 Mar 5. doi: 10.1093/jnci/djy022. [Epub ahead of print]

PMID:
29514301
32.

EZH2 regulates neuroblastoma cell differentiation via NTRK1 promoter epigenetic modifications.

Li Z, Takenobu H, Setyawati AN, Akita N, Haruta M, Satoh S, Shinno Y, Chikaraishi K, Mukae K, Akter J, Sugino RP, Nakazawa A, Nakagawara A, Aburatani H, Ohira M, Kamijo T.

Oncogene. 2018 May;37(20):2714-2727. doi: 10.1038/s41388-018-0133-3. Epub 2018 Mar 6.

33.

A case report on the successful perioperative management of hepatectomy for hepatocellular carcinoma in a patient with von Willebrand disease.

Sato K, Kuroda S, Kobayashi T, Shimizu S, Ohira M, Tahara H, Ide K, Fujii T, Ohdan H.

Int J Surg Case Rep. 2018;44:131-134. doi: 10.1016/j.ijscr.2018.02.033. Epub 2018 Feb 24.

34.

[Significance of Immune-Cell Infiltration in Gastric].

Tanaka H, Tamura T, Okita Y, Yoshii M, Tokumoto M, Go Y, Sakimura C, Hiramatsu S, Nishimura J, Yamagoe Y, Yashiro M, Miki Y, Toyokawa T, Muguruma K, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2018 Feb;45(2):217-221. Japanese.

PMID:
29483408
35.

Clinical significance of the 2016 WHO classification in Japanese patients with gliomas.

Iuchi T, Sugiyama T, Ohira M, Kageyama H, Yokoi S, Sakaida T, Hasegawa Y, Setoguchi T, Itami M.

Brain Tumor Pathol. 2018 Apr;35(2):71-80. doi: 10.1007/s10014-018-0309-0. Epub 2018 Feb 22.

PMID:
29470683
36.

Significance of tumor-infiltrating lymphocytes before and after neoadjuvant therapy for rectal cancer.

Matsutani S, Shibutani M, Maeda K, Nagahara H, Fukuoka T, Nakao S, Hirakawa K, Ohira M.

Cancer Sci. 2018 Apr;109(4):966-979. doi: 10.1111/cas.13542. Epub 2018 Mar 25.

37.

CD9-positive exosomes from cancer-associated fibroblasts stimulate the migration ability of scirrhous-type gastric cancer cells.

Miki Y, Yashiro M, Okuno T, Kitayama K, Masuda G, Hirakawa K, Ohira M.

Br J Cancer. 2018 Mar 20;118(6):867-877. doi: 10.1038/bjc.2017.487. Epub 2018 Feb 13.

PMID:
29438363
38.

[A Case of Small Intestinal Metastasis with Intussusception Due to Barium].

Tsujio G, Nagahara H, Nakao S, Fukuoka T, Shibutani M, Maeda K, Matsutani S, Kimura K, Toyokawa T, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1973-1975. Japanese.

PMID:
29394838
39.

[A Case of Bladder Metastasis from Breast Cancer].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1933-1935. Japanese.

PMID:
29394825
40.

[A Case of Breast Cancer Associated with Dermatitis That Was Difficult to Differentiate from Dermatomyositis].

Goto W, Kashiwagi S, Asano Y, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1930-1932. Japanese.

PMID:
29394824
41.

[Experience with Using the EnCor ENSPIRE®System in Mammary Tissue Biopsy].

Sera T, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1832-1834. Japanese.

PMID:
29394791
42.

[Clinical Outcome of the Patients with Anal Squamous Cell Carcinoma].

Mori T, Maeda K, Fukuoka T, Shibutani M, Nagahara H, Tamura T, Ohira G, Yamazoe S, Kimura K, Toyokawa T, Amano R, Tanaka H, Muguruma K, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1647-1649. Japanese.

PMID:
29394730
43.

[A Case of Laparoscopic Surgery Performed for Locally Advanced Rectal Cancer Suspected of Invasion to Prostate].

Nagahara H, Nakao S, Fukuoka T, Shibutani M, Maeda K, Matsutani S, Doi Y, Ohtani H, Yamazaki T, Amano R, Tanaka H, Muguruma K, Yashiro M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1523-1525. Japanese.

PMID:
29394689
44.

[Prognostic Analysis of Breast Cancer Patients Who Underwent Neoadjuvant Chemotherapy Using QOL-ACD].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1092-1094. Japanese.

PMID:
29394544
45.

[A Case of Ductal Carcinoma In Situ in Sclerosing Adenosis].

Fukui Y, Kashiwagi S, Takada K, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1089-1091. Japanese.

PMID:
29394543
46.

[A Case of Synchronous Triple Cancer of the Breast, Duodenal and Lung].

Takada K, Kashiwagi S, Amano R, Goto W, Asano Y, Ohira G, Kimura K, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1074-1076. Japanese.

PMID:
29394538
47.

[A Case of Adenoma of the Nipple Suspected of Breast Cancer].

Takada K, Kashiwagi S, Goto W, Asano Y, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1071-1073. Japanese.

PMID:
29394537
48.

[A Case of T1a Breast Cancer with Axillary Lymph Node Metastasis].

Tsujio G, Kashiwagi S, Asano Y, Goto W, Takada K, Morisaki T, Noda S, Takashima T, Onoda N, Ohsawa M, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1059-1061. Japanese.

PMID:
29394533
49.

[A Case of Breast Cancer with Local Recurrence in the Reconstructed Breast Tissue].

Tsujio G, Kashiwagi S, Hatano T, Asano Y, Goto W, Takada K, Noda S, Takashima T, Onoda N, Motomura H, Hirakawa K, Ohira M.

Gan To Kagaku Ryoho. 2017 Nov;44(12):1056-1058. Japanese.

PMID:
29394532
50.

Appropriate Use of Stents to Prevent Biliary Complications after Living Donor Liver Transplantation.

Ikegami T, Yoshizumi T, Soejima Y, Ohira M, Maehara Y.

J Am Coll Surg. 2018 Feb;226(2):201. doi: 10.1016/j.jamcollsurg.2017.10.009. No abstract available.

PMID:
29389377

Supplemental Content

Support Center